---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-021967"
form_type: "8-K"
ticker: "SCNX"
cik: "0001382574"
company_name: "Scienture Holdings, Inc."
filed_at: "2024-05-30T23:59:59+00:00"
generated_at: "2026-06-01T07:21:40.708471+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# TRxADE Health receives Nasdaq non-compliance notice for late Q1 10-Q; directors resign, new ones appointed

## Summary
- Received Nasdaq notice on May 23, 2024 for failing to timely file Q1 10-Q; must submit compliance plan by July 22, 2024.
- Potential extension to Nov 18, 2024; no immediate effect on listing or trading.
- Appointed Mayur Doshi (CEO of AlfaGene Bioscience) and Narasimhan Mani (former CEO of Kesin Pharma) as directors on May 28, 2024.
- Directors Jeff Newell and Michael Peterson voluntarily resigned on May 30, 2024; no dispute with the Company.
- Resigned directors receive cash compensation through June 30, 2024; unvested shares fully vested on resignation date.

## SEC filing metadata
- accession: 0001493152-24-021967
- form_type: 8-K
- ticker: SCNX
- cik: 0001382574
- company_name: Scienture Holdings, Inc.
- filed_at: 2024-05-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 5.02, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-021967
- JSON: https://secwatch.observer/filing/0001493152-24-021967.json
- Plain text: https://secwatch.observer/filing/0001493152-24-021967.txt

## Key facts
- Executive change
  Jeff Newell resigned as Director at Scienture Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm
- Executive change
  Narasimhan Mani was appointed as Director at Scienture Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm
- Executive change
  Michael L. Peterson resigned as Director at Scienture Holdings, Inc..
  - Action: resigned
  - Role: Director
  source text: On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm
- Executive change
  Mayur Doshi was appointed as Director at Scienture Holdings, Inc..
  - Action: appointed
  - Role: Director
  source text: On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.